CWM, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1535847 OMAHA, NE

Position in ROIV

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$5,038,602

+$4,781,826 QoQ

Shares Held

181,899

+1437.2% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.7251276807459084.ToString("F0")% Shared 0.ToString("F0")% None 99.27487231925409.ToString("F0")%

Healthcare · as of Mar 31, 2026

CWM, LLC holds $170,074,719 across 302 Biotechnology names. ROIV ranks #6 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	66,400	$51,303,296
2	MRNA	Moderna, Inc.	386,906	$19,654,824
3	INCY	Incyte Corp	202,772	$19,084,900
4	EXEL	Exelixis, Inc.	263,476	$11,300,485
5	BMRN	Biomarin Pharmaceutical Inc	159,652	$9,018,741
6	ROIV	Roivant Sciences Ltd. This page	181,899	$5,038,602
7	SRPT	Sarepta Therapeutics, Inc.	198,333	$4,315,726
8	VRTX	Vertex Pharmaceuticals Inc / Ma	8,609	$3,844,262

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,038,602	181,899	+1437.2%	Shares	Sole	2026-05-14
2025-12-31	$256,776	11,833	+281.1%	Shares	Sole	2026-01-26
2025-09-30	$46,978	3,105	+4.1%	Shares	Sole	2025-10-15
2025-06-30	$33,629	2,984	+44.6%	Shares	Sole	2025-07-25
2025-03-31	$20,825	2,064	+26.7%	Shares	Sole	2025-05-01
2024-12-31	$19,271	1,629	+66.2%	Shares	Sole	2025-02-04
2024-09-30	$11,309	980	+3983.3%	Shares	Sole	2024-10-08
2024-06-30	$253	24	+84.6%	Shares	Sole	2024-07-10
2024-03-31	$137	13	0.0%	Shares	Sole	2024-04-05
2023-12-31	$145	13	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.